As a result of the introduction of these several tests, the clinician may be faced with the problem of evaluating patients whose enzyme activity has been determined by more than one method. This ...
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study We divided the borrowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results